The present Program Project is centered on the study of the effects of cocaine and amphetamine on the signal transduction pathways of medium spiny neurons in the nucleus accumbens and neostriatum. A groups of experts in various disciplines of biomedical research proposes to carry out these studies by employing a variety of distinct but complementary approaches. Project 1 will examine the effects of acute and chronic administration of cocaine and amphetamine on the state of phosphorylation of target proteins such as phosphatase inhibitors and other intermediary transduction proteins, ion pumps, ion channels and neurotransmitter receptors. These experiments will be carried out both in vitro and in vivo using rats. Project 2 will study the possible involvement of protein phosphatase inhibitors (i.e.DARPP-32 and inhibitor-1) in the biochemical, behavioral and neurodegenerative effects of cocaine and amphetamine. This project is based on the use of mice in which the genes coding for DARPP-32 and/or inhibitor-1 have been inactivated by homologous recombination. Project 3 will be centered on the study of two other DARPP's (e.g. DARPP-16 and 21). The abundance of these phosphoproteins in nucleus accumbens and neostriatum, in particular the enrichment of DARPP-21 in the limbic striatum, and the fact that they are functionally distinct from DARPP-32 suggest that each may mediate certain of the effects of cocaine and amphetamine. The function of DARPP-16 and 21 will be investigated both by utilizing gene knock out techniques and by identifying their target proteins. Finally, the Core section will establish a general method for tissue- specific inducible knock out of selected genes, including those coding for DARPP-32, 21 and 16, and inhibitor-1. The Core will provide maintenance for all colonies of transgenic and knock out mice and will produce and maintain primary cell cultures from rat brain. A supply of key reagents, such as enzymes and antibodies (including phosphorylation state-specific antibodies), will be provided by the Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA010044-04
Application #
2882607
Study Section
Special Emphasis Panel (SRCD (21))
Program Officer
Satterlee, John S
Project Start
1996-04-01
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Other Basic Sciences
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Li, Daniel; Musante, Veronica; Zhou, Wenliang et al. (2018) Striatin-1 is a B subunit of protein phosphatase PP2A that regulates dendritic arborization and spine development in striatal neurons. J Biol Chem 293:11179-11194
Seo, J-S; Zhong, P; Liu, A et al. (2018) Elevation of p11 in lateral habenula mediates depression-like behavior. Mol Psychiatry 23:1113-1119
Madero-Pérez, Jesús; Fdez, Elena; Fernández, Belén et al. (2018) Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation. Mol Neurodegener 13:3
Chang, Audrey N; Gao, Ning; Liu, Zhenan et al. (2018) The dominant protein phosphatase PP1c isoform in smooth muscle cells, PP1c?, is essential for smooth muscle contraction. J Biol Chem 293:16677-16686
Andrade, Erika C; Musante, Veronica; Horiuchi, Atsuko et al. (2017) ARPP-16 Is a Striatal-Enriched Inhibitor of Protein Phosphatase 2A Regulated by Microtubule-Associated Serine/Threonine Kinase 3 (Mast 3 Kinase). J Neurosci 37:2709-2722
Musante, Veronica; Li, Lu; Kanyo, Jean et al. (2017) Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition. Elife 6:
Milosevic, Ana; Liebmann, Thomas; Knudsen, Margarete et al. (2017) Cell- and region-specific expression of depression-related protein p11 (S100a10) in the brain. J Comp Neurol 525:955-975
Ceglia, Ilaria; Lee, Ko-Woon; Cahill, Michael E et al. (2017) WAVE1 in neurons expressing the D1 dopamine receptor regulates cellular and behavioral actions of cocaine. Proc Natl Acad Sci U S A 114:1395-1400
Seo, J-S; Wei, J; Qin, L et al. (2017) Cellular and molecular basis for stress-induced depression. Mol Psychiatry 22:1440-1447
Nishi, Akinori; Matamales, Miriam; Musante, Veronica et al. (2017) Glutamate Counteracts Dopamine/PKA Signaling via Dephosphorylation of DARPP-32 Ser-97 and Alteration of Its Cytonuclear Distribution. J Biol Chem 292:1462-1476

Showing the most recent 10 out of 205 publications